Katja Pfafferott

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Vaccination, Vaccine Safety, Phase 1/2 +7

HIV evolution: CTL escape mutation and reversion after transmission

Alasdair Leslie, Katja Pfafferott, Polan Chetty et al. · Nature Medicine · 2004 · 846 citations

Viral Evolution, Human Retrovirus, Immunology +6

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA

Photini Kiepiela, Alasdair Leslie, Isobella Honeyborne et al. · Nature · 2004 · 833 citations

Viral Persistence, Human Leukocyte Antigen, Human Retrovirus +12

Adaptation of HIV-1 to human leukocyte antigen class I

Yuka Kawashima, Katja Pfafferott, John Frater et al. · Nature · 2009 · 464 citations · Full text

Primary Immunodeficiency, Human Retrovirus, Immunology +4

Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1

Javier Martínez‐Picado, Júlia G. Prado, Elizabeth E. Fry et al. · Journal of Virology · 2006 · 440 citations · Full text

Immunology, Mutational Escape, Human Immunodeficiency Virus +17